Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Higher Tissue Factor (TF) Expression in the Lungs of COVID-19 Pneumonia Patients Than Patients with Acute Respiratory Distress Syndrome: Association with Thrombi Formation

Sandeep Subrahmanian, PhD, Alain Borczuk, MD, Steven P. Salvatore, MD, Jeffrey Laurence, MD, Jasimuddin Ahamed, PhD

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-142827

Published: 2020

Journal Articles

Triggers in Patients with Atypical Hemolytic Uremic Syndrome: An Observational Cohort Study Using a US Claims Database

Ioannis Tomazos, Katherine Garlo, Yan Wang, Peter Chen, Jeffrey Laurence, MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136278

Published: 2020

Journal Articles

Masp-2 Levels Following Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Correlation with Development of a Thrombotic Microangiopathy and Implications for Therapy with Anti-Complement Agents

Jeffrey Laurence, MD, Koen Van Besien, MD PhD, Jasimuddin Ahamed, PhD, Sonia Elhadad, PhD

Blood (2019) 134 (Supplement_1): 3305.

https://doi.org/10.1182/blood-2019-130919

Published: 2019

Journal Articles

Differential Effects of HIV Protease Inhibitors on Release and Activation of Platelet-Derived TGF-β1: Potential Association with HIV-Linked CVD

Kouzbari Karim, DDS, Gostynska Sandra, MS, Sonia Elhadad, PhD, Dube Pratibha, MS, Jeffrey Laurence, MD, Jasimuddin Ahamed, PhD

Blood (2019) 134 (Supplement_1): 2341.

https://doi.org/10.1182/blood-2019-126225

Published: 2019

Journal Articles

Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies

Jeffrey Laurence, MD, Sonia Elhadad, PhD

Blood (2019) 134 (Supplement_1): 3676.

https://doi.org/10.1182/blood-2019-124158

Published: 2019

Journal Articles

Economic Benefit of Early Inhospital Diagnosis and Treatment Initiation of Eculizumab in aHUS

Bonnie M.K. Donato, PhD, Michael Ryan, MS, William Irish, PhD, Christoph Gasteyger, MD, Gilbert L'Italien, PhD, Jeffrey Laurence, MD

Blood (2018) 132 (Supplement 1): 3565.

https://doi.org/10.1182/blood-2018-99-112893

Published: 2018

Journal Articles

Elevation of Circulating Terminal Complement Components in aHUS and TTP: Utility of Genetic Testing to Differentiate Among Thrombotic Microangiopathies

John C. Chapin, MD, Jeffrey Laurence, MD, Jasimuddin Ahamed, PhD

Blood (2014) 124 (21): 4202.

https://doi.org/10.1182/blood.V124.21.4202.4202

Published: 2014

Journal Articles

Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies

John Chapin, Stephen Eyler, Richard Smith, Han-Mou Tsai, Jeffrey Laurence

Blood (2013) 121 (19): 4012–4013.

https://doi.org/10.1182/blood-2013-03-487694

Published: 2013

Journal Articles

The Alternate Complement Pathway in Thrombotic Thrombocytopenic Purpura

John C. Chapin, MD, Katrina Piskorski, Stephen J Eyler, MD, Richard J. H. Smith, MD, Jeffrey Laurence, MD

Blood (2012) 120 (21): 3342.

https://doi.org/10.1182/blood.V120.21.3342.3342

Published: 2012

Journal Articles

Use of Anti-C5 Monoclonal Antibody Eculizumab in the Treatment of a Patient with Refractory Idiopathic Thrombotic Thrombocytopenic Purpura (TTP)

John C. Chapin, MD, Adriana C Rossi, MD, Ashish Saxena, MD, PhD, Bruce Gordon, MD, Babette B. Weksler, MD, Cynthia Magro, MD, Jeffrey Laurence, MD

Blood (2011) 118 (21): 4666.

https://doi.org/10.1182/blood.V118.21.4666.4666

Published: 2011

Journal Articles

Synergistic interactions between interferon-γ and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma–associated apoptosis

Radu Stefanescu, Dustin Bassett, Rozbeh Modarresi, Francisco Santiago, Mohamad Fakruddin, Jeffrey Laurence

Blood (2008) 112 (2): 340–349.

https://doi.org/10.1182/blood-2007-10-119552

Published: 2008

Journal Articles

Association of Complement with Microvascular Endothelial Cell Injury in Thrombotic Microangiopathy In Vivo and in In Vitro Model Systems.

Brian A. Di Carlo, MD, Radu Stefanescu, MD, Kelvin Lee, PhD, Wei Yin, PhD, Rozbeh Modaressi, PhD, Ellinor I.B. Peerschke, MD, Jeffrey Laurence, MD

Blood (2006) 108 (11): 1465.

https://doi.org/10.1182/blood.V108.11.1465.1465

Published: 2006

Journal Articles

Enhanced Endothelial Cell Apoptosis in Splenic Tissues of Patients With Thrombotic Thrombocytopenic Purpura

Chau T. Dang, Margret S. Magid, Babette Weksler, Amy Chadburn, Jeffrey Laurence

Blood (1999) 93 (4): 1264–1270.

https://doi.org/10.1182/blood.V93.4.1264

Published: 1999

Journal Articles

Thrombotic Thrombocytopenic Purpura and Sporadic Hemolytic-Uremic Syndrome Plasmas Induce Apoptosis in Restricted Lineages of Human Microvascular Endothelial Cells

Debashis Mitra, Eric A. Jaffe, Babette Weksler, Katherine A. Hajjar, Carl Soderland, Jeffrey Laurence

Blood (1997) 89 (4): 1224–1234.

https://doi.org/10.1182/blood.V89.4.1224

Published: 1997

NARROW

Higher Tissue Factor (TF) Expression in the Lungs of COVID-19 Pneumonia Patients Than Patients with Acute Respiratory Distress Syndrome: Association with Thrombi Formation

Triggers in Patients with Atypical Hemolytic Uremic Syndrome: An Observational Cohort Study Using a US Claims Database

Masp-2 Levels Following Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Correlation with Development of a Thrombotic Microangiopathy and Implications for Therapy with Anti-Complement Agents

Differential Effects of HIV Protease Inhibitors on Release and Activation of Platelet-Derived TGF-β1: Potential Association with HIV-Linked CVD

Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies

Economic Benefit of Early Inhospital Diagnosis and Treatment Initiation of Eculizumab in aHUS

Elevation of Circulating Terminal Complement Components in aHUS and TTP: Utility of Genetic Testing to Differentiate Among Thrombotic Microangiopathies

Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies

The Alternate Complement Pathway in Thrombotic Thrombocytopenic Purpura

Use of Anti-C5 Monoclonal Antibody Eculizumab in the Treatment of a Patient with Refractory Idiopathic Thrombotic Thrombocytopenic Purpura (TTP)

Synergistic interactions between interferon-γ and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma–associated apoptosis

Association of Complement with Microvascular Endothelial Cell Injury in Thrombotic Microangiopathy In Vivo and in In Vitro Model Systems.

Enhanced Endothelial Cell Apoptosis in Splenic Tissues of Patients With Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura and Sporadic Hemolytic-Uremic Syndrome Plasmas Induce Apoptosis in Restricted Lineages of Human Microvascular Endothelial Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only